Psychemedics Corporation Earns Prestigious Recognition for Superior Customer Service

Award-Winning Customer Support Team is now a “Certified Center of Excellence” ACTON, Mass., Sept. 13, 2016 /PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD), the world’s leading and largest hair analysis drug testing company, announced that it has been certified as a Center of Excellence by BenchmarkPortal. The Center of Excellence recognition is one of the most prestigious … Read more

Psychemedics Corporation Announces Record Revenues And Earnings

DECLARES 80th CONSECUTIVE DIVIDEND — 20 YEARS OF QUARTERLY DIVIDENDS ACTON, Mass., July 26, 2016,/PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced second-quarter financial results for the period ended June 30, 2016.  The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 5, 2016, to be … Read more

Psychemedics Announces Addition Of FDA Cleared Drugs

World’s largest hair drug testing company & scientific leader launches new screening tests for Oxymorphone and D-Amphetamine/Adderall®. ACTON, Mass., June 2, 2015 /PRNewswire/ — Psychemedics Corporation PMD, -0.06% hair testing pioneer and global leader for over twenty-five years, announced the addition of 2 new drugs to the company’s drug testing panels. In response to growing … Read more

Psychemedics Corporation Announces Record Revenues

DECLARES 74th CONSECUTIVE QUARTERLY DIVIDEND Acton, Massachusetts, February 10, 2015 — Psychemedics Corporation (NASDAQ: PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2014.  The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of February 23, 2015, to be paid on … Read more